Search

Background: Contact allergy in children is becoming increasingly recognized as a cause of eczema. The causal agents may change with time, but there are few comparative data for this age group., Objectives: To compare data from the past 10 years with a similar study from the previous decade., Methods: Between 2005 and 2014, 500 consecutive children who had been patch tested at Leeds Teaching Hospitals were identified, and the results were reviewed., Results: Twenty-seven per cent (134 cases) of children had one or more positive patch test findings. The mean ± standard deviation age of patients with a positive test reaction was 11.9 ± 4.1 years, which was significantly higher than that of patients with a negative result (10.9 ± 4.0 years) (p = 0.01; Mann-Whitney U-test). No significant relationship between sex and a positive patch test result was found (p = 0.48, chi-squared). Allergy to nickel was the most frequent finding, although this accounted for 18%, rather than 33% (1995-2004), of all positive reactions. The next most common allergens included fragrance mix 1 (17%), p-phenylenediamine (16%), and methylchloroisothiazolinone/methylisothiazolinone (6%)., Conclusions: Although the overall incidence of contact allergy in our paediatric population is static, there has been a significant change in the allergens detected, probably as a result of changes in European legislation and cosmetic product use in children., (© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)

We report the second case of autosomal dominant familial annular erythema since its original description in 1966 by Beare et al. A three and a half-year-old boy presented at five days of age with a widespread annular urticated erythematous rash which has persisted despite treatment with various antihistamines and mast-cell stabilizers. His mother reports an identical eruption with an absence of systemic symptoms., (© 2011 Wiley Periodicals, Inc.)

In the current financial climate where resources in the National Health Service are becoming increasingly limited, it is essential that the role of the pediatric dermatology nurse specialist remains appreciated and supported. Our pediatric dermatology nurse specialist was first employed in September 2002 having had 6 years experience nursing children with a wide variety of dermatologic conditions prior to her employment. She achieved her pediatric community nursing degree in 2003 undertaking the nurse prescribing extended formulary course in 2006, her training history representative of many nurse specialists. We present the results of an audit highlighting how the employment of our pediatric dermatology nurse specialist has led to a decrease in hospital admissions as well as providing a significant positive impact on waiting lists.